Ad is loading...
PCSMX
Price
$16.90
Change
+$0.30 (+1.81%)
Updated
Nov 21 closing price
VISGX
Price
$82.23
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

PCSMX vs VISGX

Header iconPCSMX vs VISGX Comparison
Open Charts PCSMX vs VISGXBanner chart's image
Principal SmallCap Growth I R6
Price$16.90
Change+$0.30 (+1.81%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Growth Index I
Price$82.23
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
PCSMX vs VISGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PCSMX vs. VISGX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCSMX is a StrongBuy and VISGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 35.8B vs. PCSMX (2.24B). VISGX pays higher dividends than PCSMX: VISGX (0.55) vs PCSMX (0.00). PCSMX was incepted earlier than VISGX: PCSMX (10 years) vs VISGX (27 years). PCSMX is a more actively managed with annual turnover of: 50.30 vs. VISGX (19.00). PCSMX has a lower initial minimum investment than VISGX: PCSMX (0) vs VISGX (3000). VISGX annual gain was more profitable for investors over the last year : 35.67 vs. PCSMX (32.65). VISGX return over 5 years is better than : 53.45 vs. PCSMX (21.15).
PCSMXVISGXPCSMX / VISGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years27 years-
Gain YTD19.43521.20692%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.24B35.8B6%
Annual Yield % from dividends0.000.55-
Returns for 1 year32.6535.6792%
Returns for 3 years-16.671.53-1,090%
Returns for 5 years21.1553.4540%
Returns for 10 yearsN/A136.51-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZG79.264.26
+5.68%
Zillow Group
WOOF4.170.20
+5.04%
Petco Health and Wellness Company
PTGX41.651.00
+2.46%
Protagonist Therapeutics
MVO9.140.06
+0.66%
MV Oil Trust
HSDT0.43-0.02
-4.87%
Helius Medical Technologies